03February

Novo Nordisk increased operating profit by 43% in 2015 to DKK 49.4 billion ... Read more

29January

Tresiba® demonstrates significantly lower rate of hypoglycaemia than insulin gla ... Read more

07January

Novo Nordisk files for regulatory approval of long-acting factor IX in the EU fo ... Read more

18December

Novo Nordisk and C40 partner to improve environment and health in cities ... Read more

04February

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives an ... Read more

03February

Novo Nordisk increased operating profit by 43% in 2015 to DKK 49.4 billion ... Read more

02February

Novo Nordisk A/S - Share repurchase programme ... Read more

29January

Tresiba® demonstrates significantly lower rate of hypoglycaemia than insulin gla ... Read more

07February

Q4 roadshow, Europe

07February

Q4 roadshow, USA

08March

LEERINK Partners Global Healthcare Conference, New York

01March

Credit Suisse One-on-One Healthcare Conference, London

 

 

 

Investors

 
Share information


Take an advanced view of the Novo Nordisk share

 
Capital Markets Day 2015


Access the webcast and presentations for the CMD

 
Q4 financial results


Access the conference call for the Q4 results



Novo Nordisk at a glance


Private shareholders


See relevant content for private investors



IR material


Download relevant Investor Relations material



Contacts



Subscriptions


Sign up to receive company announcements.



Annual Report


Download the Novo Nordisk Annual Report